Global Personalizing Cancer Drugs Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 107

Report ID: 3890

Global cancer drugs market is primarily driven by growing incidences of target disease such as lung cancer, breast cancer, cervical cancer, etc. across the globe. Other major driving factors are increasing research and development on biological and targeted drug therapies for the treatment of cancer coupled along with the expiration of patents.
In 2018, the global Personalizing Cancer Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of 6.9% during 2019-2025.

This report focuses on the global Personalizing Cancer Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Personalizing Cancer Drugs development in United States, Europe and China.

The key players covered in this study
Bayer
GlaxoSmithKline
Novartis
Sanofi
Pfizer
Amgen
Merck
Bristol-Myers Squibb
Celgene Corporation
Ariad Pharmaceuticals
Eli Lilly
Hoffmann-La Roche
Boehringer Ingelheim
Johnson and Johnson
Teva Pharmaceuticals

Market segment by Type, the product can be split into
Immunotherapy
Targeted Therapy
Chemotherapy
Hormone Therapy
Others

Market segment by Application, split into
Breast Cancer
Blood Cancer
Gastrointestinal Cancer
Prostate Cancer
Skin Cancer
Lung Cancer
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Personalizing Cancer Drugs status, future forecast, growth opportunity, key market and key players.
To present the Personalizing Cancer Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Personalizing Cancer Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Personalizing Cancer Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Immunotherapy
1.4.3 Targeted Therapy
1.4.4 Chemotherapy
1.4.5 Hormone Therapy
1.4.6 Others
1.5 Market by Application
1.5.1 Global Personalizing Cancer Drugs Market Share by Application (2014-2025)
1.5.2 Breast Cancer
1.5.3 Blood Cancer
1.5.4 Gastrointestinal Cancer
1.5.5 Prostate Cancer
1.5.6 Skin Cancer
1.5.7 Lung Cancer
1.5.8 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Personalizing Cancer Drugs Market Size
2.2 Personalizing Cancer Drugs Growth Trends by Regions
2.2.1 Personalizing Cancer Drugs Market Size by Regions (2014-2025)
2.2.2 Personalizing Cancer Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Personalizing Cancer Drugs Market Size by Manufacturers
3.1.1 Global Personalizing Cancer Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Personalizing Cancer Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Personalizing Cancer Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Personalizing Cancer Drugs Key Players Head office and Area Served
3.3 Key Players Personalizing Cancer Drugs Product/Solution/Service
3.4 Date of Enter into Personalizing Cancer Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Personalizing Cancer Drugs Market Size by Type (2014-2019)
4.2 Global Personalizing Cancer Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Personalizing Cancer Drugs Market Size (2014-2019)
5.2 Personalizing Cancer Drugs Key Players in United States
5.3 United States Personalizing Cancer Drugs Market Size by Type
5.4 United States Personalizing Cancer Drugs Market Size by Application

6 Europe
6.1 Europe Personalizing Cancer Drugs Market Size (2014-2019)
6.2 Personalizing Cancer Drugs Key Players in Europe
6.3 Europe Personalizing Cancer Drugs Market Size by Type
6.4 Europe Personalizing Cancer Drugs Market Size by Application

7 China
7.1 China Personalizing Cancer Drugs Market Size (2014-2019)
7.2 Personalizing Cancer Drugs Key Players in China
7.3 China Personalizing Cancer Drugs Market Size by Type
7.4 China Personalizing Cancer Drugs Market Size by Application

8 Japan
8.1 Japan Personalizing Cancer Drugs Market Size (2014-2019)
8.2 Personalizing Cancer Drugs Key Players in Japan
8.3 Japan Personalizing Cancer Drugs Market Size by Type
8.4 Japan Personalizing Cancer Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Personalizing Cancer Drugs Market Size (2014-2019)
9.2 Personalizing Cancer Drugs Key Players in Southeast Asia
9.3 Southeast Asia Personalizing Cancer Drugs Market Size by Type
9.4 Southeast Asia Personalizing Cancer Drugs Market Size by Application

10 India
10.1 India Personalizing Cancer Drugs Market Size (2014-2019)
10.2 Personalizing Cancer Drugs Key Players in India
10.3 India Personalizing Cancer Drugs Market Size by Type
10.4 India Personalizing Cancer Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Personalizing Cancer Drugs Market Size (2014-2019)
11.2 Personalizing Cancer Drugs Key Players in Central & South America
11.3 Central & South America Personalizing Cancer Drugs Market Size by Type
11.4 Central & South America Personalizing Cancer Drugs Market Size by Application

12 International Players Profiles
12.1 Bayer
12.1.1 Bayer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Personalizing Cancer Drugs Introduction
12.1.4 Bayer Revenue in Personalizing Cancer Drugs Business (2014-2019)
12.1.5 Bayer Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Company Details
12.2.2 Company Description and Business Overview
12.2.3 Personalizing Cancer Drugs Introduction
12.2.4 GlaxoSmithKline Revenue in Personalizing Cancer Drugs Business (2014-2019)
12.2.5 GlaxoSmithKline Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Personalizing Cancer Drugs Introduction
12.3.4 Novartis Revenue in Personalizing Cancer Drugs Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Sanofi
12.4.1 Sanofi Company Details
12.4.2 Company Description and Business Overview
12.4.3 Personalizing Cancer Drugs Introduction
12.4.4 Sanofi Revenue in Personalizing Cancer Drugs Business (2014-2019)
12.4.5 Sanofi Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Personalizing Cancer Drugs Introduction
12.5.4 Pfizer Revenue in Personalizing Cancer Drugs Business (2014-2019)
12.5.5 Pfizer Recent Development
12.6 Amgen
12.6.1 Amgen Company Details
12.6.2 Company Description and Business Overview
12.6.3 Personalizing Cancer Drugs Introduction
12.6.4 Amgen Revenue in Personalizing Cancer Drugs Business (2014-2019)
12.6.5 Amgen Recent Development
12.7 Merck
12.7.1 Merck Company Details
12.7.2 Company Description and Business Overview
12.7.3 Personalizing Cancer Drugs Introduction
12.7.4 Merck Revenue in Personalizing Cancer Drugs Business (2014-2019)
12.7.5 Merck Recent Development
12.8 Bristol-Myers Squibb
12.8.1 Bristol-Myers Squibb Company Details
12.8.2 Company Description and Business Overview
12.8.3 Personalizing Cancer Drugs Introduction
12.8.4 Bristol-Myers Squibb Revenue in Personalizing Cancer Drugs Business (2014-2019)
12.8.5 Bristol-Myers Squibb Recent Development
12.9 Celgene Corporation
12.9.1 Celgene Corporation Company Details
12.9.2 Company Description and Business Overview
12.9.3 Personalizing Cancer Drugs Introduction
12.9.4 Celgene Corporation Revenue in Personalizing Cancer Drugs Business (2014-2019)
12.9.5 Celgene Corporation Recent Development
12.10 Ariad Pharmaceuticals
12.10.1 Ariad Pharmaceuticals Company Details
12.10.2 Company Description and Business Overview
12.10.3 Personalizing Cancer Drugs Introduction
12.10.4 Ariad Pharmaceuticals Revenue in Personalizing Cancer Drugs Business (2014-2019)
12.10.5 Ariad Pharmaceuticals Recent Development
12.11 Eli Lilly
12.12 Hoffmann-La Roche
12.13 Boehringer Ingelheim
12.14 Johnson and Johnson
12.15 Teva Pharmaceuticals

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details